Literature DB >> 19567201

The mechanism of chemokine receptor 9 internalization triggered by interleukin 2 and interleukin 4.

Xiaoling Tong1, Lijun Zhang, Li Zhang, Meng Hu, Jun Leng, Beibei Yu, Beibei Zhou, Yi Hu, Qiuping Zhang.   

Abstract

In previous study, we found that the chemokine receptor 9 (CCR9) was highly expressed on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia (T-ALL) and mediated leukemia cell infiltration and metastasis. Combined use of interleukin 2 (IL-2) and IL-4 promoted the internalization of CCR9 and therefore attenuated leukemia cell infiltration and metastasis. In this study, we preliminarily investigated the mechanism of internalization of CCR9 on MOLT4 cell model (a human leukemia T-cell line, naturally expresses CCR9) and found that IL-2 upregulated the cell surface expression of IL-4Ralpha (CD124) greatly, whereas IL-4 had no significant influence on alpha (CD25) and beta subunits (CD122) of IL-2R. Moreover, specific inhibitors, such as staurosporine, H89 and heparin, inhibited internalization of CCR9, which indicated a role of protein kinase C (PKC) and G protein-coupled kinase 2 (GRK2), respectively. Furthermore, GRK2 was upregulated and translocated to cell membrane in IL-2 and IL-4 treated cells which indicated that PKC could be a prerequisite for GRK2 activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567201      PMCID: PMC4003061          DOI: 10.1038/cmi.2009.25

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  6 in total

Review 1.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

2.  Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns.

Authors:  Hung-Bo Hsiao; Ai-Hsiang Chou; Su-I Lin; I-Hua Chen; Shu-Pei Lien; Chia-Chyi Liu; Pele Chong; Shih-Jen Liu
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

Review 3.  CCR9 in cancer: oncogenic role and therapeutic targeting.

Authors:  Zhenbo Tu; Ruijing Xiao; Jie Xiong; Kingsley M Tembo; Xinzhou Deng; Meng Xiong; Pan Liu; Meng Wang; Qiuping Zhang
Journal:  J Hematol Oncol       Date:  2016-02-16       Impact factor: 17.388

Review 4.  The G Protein-Coupled Receptor Kinases (GRKs) in Chemokine Receptor-Mediated Immune Cell Migration: From Molecular Cues to Physiopathology.

Authors:  Marta Laganà; Géraldine Schlecht-Louf; Françoise Bachelerie
Journal:  Cells       Date:  2021-01-05       Impact factor: 6.600

Review 5.  Targeting chemokines for acute lymphoblastic leukemia therapy.

Authors:  Zixi Hong; Zimeng Wei; Tian Xie; Lin Fu; Jiaxing Sun; Fuling Zhou; Muhammad Jamal; Qiuping Zhang; Liang Shao
Journal:  J Hematol Oncol       Date:  2021-03-20       Impact factor: 17.388

6.  Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.

Authors:  Li Zhang; Ruijing Xiao; Jie Xiong; Jun Leng; Altaf Ehtisham; Yi Hu; Qianshan Ding; Hui Xu; Shengwu Liu; Jin Wang; Dean G Tang; Qiuping Zhang
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.